{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:58:20Z","timestamp":1790780300901,"version":"4.1.0"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2019.00344","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T23:57:40Z","timestamp":1578441460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia"],"prefix":"10.3389","volume":"11","author":[{"given":"Miren","family":"Ettcheto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Olloquequi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Regina","family":"Manzine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Beas-Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n D.","family":"Castro-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Bull\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Auladell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Folch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Camins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neuropharm.2017.08.012","article-title":"Neuropharmacology selective inhibition of extra-synaptic a 5-GABA A receptors by S44819, a new therapeutic agent","volume":"125","author":"Adrienn","year":"2017","journal-title":"Neuropharmacology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/pr.117.014381","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use","volume":"18","author":"Barker","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jalz.2014.08.104","article-title":"Self-reported sleep disturbance is associated with Alzheimer's disease risk in men","volume":"11","author":"Benedict","year":"2015","journal-title":"Alzheimers Dement"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/gps.1811","article-title":"The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?","volume":"22","author":"Bierman","year":"2007","journal-title":"Int J Geriatr. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40263-016-0404-x","article-title":"Benzodiazepine use and Risk of developing Alzheimer's disease: a case-control study based on Swiss claims data","volume":"31","author":"Bi\u00e9try","year":"2017","journal-title":"CNS Drugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer' s disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00228-011-1047-y","article-title":"Impact of long-term benzodiazepine use on cognitive functioning in young adults: The VISAT cohort","volume":"67","author":"Boeuf-Cazou","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.sleep.2018.09.001","article-title":"Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications","volume":"52","author":"Burke","year":"2018","journal-title":"Sleep Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1073\/pnas.0307231101","article-title":"Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by 5 subunit-containing -aminobutyric acid type A receptors","volume":"101","author":"Caraiscos","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/anae.13938","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals","volume":"72","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jalz.2015.03.004","article-title":"Sleep duration, cognitive decline, and dementia risk in older women","volume":"12","author":"Chen","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e49113","DOI":"10.1371\/journal.pone.0049113","article-title":"Risk of dementia in patients with insomnia and long- term use of hypnotics: a population-based retrospective cohort study","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.3233\/JAD-179911","article-title":"Alzheimer's disease: from basic neurobiology to clinical approaches","volume":"64","author":"Clarke","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.5664\/jcsm.1360","article-title":"Biochemical regulation of sleep and sleep biomarkers","volume":"7","author":"Clinton","year":"2011","journal-title":"J. Clin. Sleep Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1176\/foc.7.4.foc538","article-title":"NIH state-of-the-science conference statement on manifestations and management of chronic insomnia in adults","volume":"7","author":"Consensus","year":"2014","journal-title":"Focus"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.neurobiolaging.2014.02.011","article-title":"Neurobiology of Aging sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer' s disease with plaques and tangles","volume":"35","author":"Di Meco","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00023210-200721050-00003","article-title":"Use of non-benzodiazepine hypnotics in the elderly are all agents the same?","volume":"21","author":"Dolder","year":"2007","journal-title":"CNS Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1124\/jpet.118.249250","article-title":"Evidence that sedative effects of benzodiazepines involve unexpected GABA A receptor subtypes: quantitative observation studies in Rhesus monkeys","volume":"366","author":"Duke","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/jnnp.2006.104034","article-title":"The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate or deterioration","volume":"78","author":"Ellul","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","article-title":"Benzodiazepines may have protective effects against Alzheimer disease","volume":"12","author":"Fastbom","year":"1998","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","article-title":"Synaptic impairment in Alzheimer's disease: a dysregulated symphony","volume":"40","author":"Forner","year":"2017","journal-title":"Trends Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnins.2018.00037","article-title":"Challenges for Alzheimer's disease therapy: insights from novel mechanisms beyond memory defects","volume":"12","author":"Frozza","year":"2018","journal-title":"Front. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1517\/14740338.2015.1014796","article-title":"Is there really a link between benzodiazepine use and the risk of dementia?","volume":"14","author":"Gage","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"B26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (caps)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J. Epidemiol. Community Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Gaugler","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"Br. Med. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/JAD-151006","article-title":"Regular benzodiazepine and Z-substance use and risk of dementia: an analysis of german claims data","volume":"54","author":"Gomm","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1017\/S104161021700223X","article-title":"Use of benzodiazepines and cognitive performance in primary care patients with first cognitive complaints","volume":"30","author":"Grande","year":"2019","journal-title":"Int. Psychogeriatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s13181-013-0294-y","article-title":"In the Zzz zone: the effects of Z-drugs on human performance and driving","volume":"9","author":"Gunja","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/jnc.14345","article-title":"The GABAergic system as a therapeutic target for Alzheimer's disease","volume":"146","author":"Guzm\u00e1n","year":"2018","journal-title":"J. Neurochem."},{"key":"B34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-397032-9.00006-6","article-title":"The chemical synapses,","volume-title":"Cellular and Molecular Neurophysiology, 4th Edn","author":"Hammond","year":"2015"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3988\/jcn.2019.15.1.9","article-title":"Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies","volume":"15","author":"He","year":"2019","journal-title":"J. Clin. Neurol."},{"key":"B36","first-page":"53","article-title":"Sleep and attention in alzheimer's disease","volume":"92","author":"Hennawy","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0044-100523","article-title":"Prescription of benzodiazepines and related drugs in patients with mild cognitive deficits and Alzheimer's disease","volume":"52","author":"Hessmann","year":"2019","journal-title":"Pharmacopsychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/YIC.0000000000000230","article-title":"Continuity of treatment with benzodiazepines in dementia patients: an analysis of German health insurance claims data","volume":"33","author":"Hessmann","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing Alzheimer' s disease or vascular dementia: a case \u2013 control analysis","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Saf."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"Investigations","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.euroneuro.2012.05.003","article-title":"Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of \u03b1 1 GABA A receptors","volume":"23","author":"Joksimovi\u0107","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1523\/JNEUROSCI.3606-03.2004","article-title":"Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABAA receptor phosphorylation, activity, and cell-surface stability","volume":"24","author":"Jovanovic","year":"2004","journal-title":"J. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","article-title":"Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-\u03b2 oligomers in mice","volume":"64","author":"Kincheski","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2012-000850","article-title":"Hypnotics' association with mortality or cancer: a matched cohort study","volume":"2","author":"Kripke","year":"2012","journal-title":"BMJ Open"},{"key":"B45","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3233\/JAD-180745","article-title":"Diazepam toxicity presenting as a dementia disorder","volume":"66","author":"Kurlawala","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jalz.2017.07.446","article-title":"Are care home residents with undiagnosed dementia more at risk of antipsychotic overuse? Alzheimer's Dement. J","volume":"13","author":"La Frenais","year":"2017","journal-title":"Alzheimer's Assoc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0895-4356(01)00453-X","article-title":"Benzodiazepine use and risk of dementia: a nested case \u2013 control study","volume":"55","author":"Lagnaoui","year":"2002","journal-title":"J. Clin. Epidemiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0204413","DOI":"10.1371\/journal.pone.0204413","article-title":"Use of sedative-hypnotics and the risk of Alzheimer' s dementia: a retrospective cohort study","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS ONE"},{"key":"B49","article-title":"Drugs for chronic insomnia","volume":"60","author":"Letter","year":"2019","journal-title":"Med. Lett."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/archneur.56.10.1266","article-title":"Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease","volume":"56","author":"Lopez","year":"1999","journal-title":"Arch. Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/phar.2170","article-title":"Association between development of dementia and use of benzodiazepines: a systematic review and meta-analysis","volume":"38","author":"Lucchetta","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pbb.2012.12.018","article-title":"Pharmacology, biochemistry and behavior cognition-impairing effects of benzodiazepine-type drugs: role of GABA A receptor subtypes in an executive function task in rhesus monkeys","volume":"104","author":"Makaron","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1084\/jem.20161731","article-title":"Tau deletion promotes brain insulin resistance","volume":"214","author":"Marciniak","year":"2017","journal-title":"J. Exp. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1515\/REVNEURO.1995.6.3.221","article-title":"GABAergic Deafferentation hypothesis of brain aging and Alzheimer' s disease; pharmacologic profile of the benzodiazepine antagonist, Flumazenil","volume":"258","author":"Marczynski","year":"1995","journal-title":"Rev. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0361-9230(97)00347-X","article-title":"GABAergic deafferentation hypothesis of brain aging and Alzheimer' s disease revisited","volume":"45","author":"Marczynski","year":"1998","journal-title":"Brain Res. Bull."},{"key":"B57","first-page":"a501","article-title":"Benzodiazepines revisited","volume":"5","author":"Mehdi","year":"2012","journal-title":"Br. J. Med. Pract."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009178","article-title":"Pharmacotherapies for sleep disturbances in Alzheimer's disease (Protocol)","author":"Modabbernia","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12031-018-1246-4","article-title":"The \u03b1 5-containing GABA A receptors \u2014 a brief summary","volume":"67","author":"Mohamad","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2147\/CIA.S87466","article-title":"Potential drug\u2013drug interactions in Alzheimer patients with behavioral symptoms","volume":"2015","author":"Monzani","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"B61","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.euroneuro.2012.05.004","article-title":"Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the three-city study","volume":"23","author":"Mura","year":"2013","journal-title":"Eur. Neuropsychopharmacol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160828","article-title":"Psychotropic polypharmacy in patients with dementia: prevalence and predictors","volume":"56","author":"N\u00f8rgaard","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1155\/NP.2005.289","article-title":"Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes","volume":"12","author":"Obradovi","year":"2005","journal-title":"Nural Plast."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The benzodiazepine \u2013 dementia disorders link: current state of knowledge","volume":"30","author":"Pariente","year":"2016","journal-title":"CNS Drugs"},{"key":"B65","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00004714-200206000-00009","article-title":"Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study","volume":"22","author":"Paterniti","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"100133","DOI":"10.1016\/j.ynstr.2018.10.001","article-title":"Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease","volume":"10","author":"Phan","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"B67","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/pds.853","article-title":"Benzodiazepine utilization patterns in Alzheimer' s disease patients","volume":"12","author":"Pharmd","year":"2003","journal-title":"Pharmacoepidemiol. Drug Saf"},{"key":"B68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2146\/ajhp160381","article-title":"Benzodiazepine use and cognitive decline in the elderly","volume":"75","author":"Picton","year":"2018","journal-title":"Am. J. Health-Syst Pharm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/jamapsychiatry.2014.2476","article-title":"Amyloid-\u03b2, anxiety, and cognitive decline in preclinical alzheimer disease a multicenter, prospective cohort study","volume":"72","author":"Pietrzak","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/JCP.0b013e318222810e","article-title":"Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE \u03b54-negative elderly","volume":"31","author":"Pomara","year":"2011","journal-title":"J. Clin. Psychopharmacol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"P1622","DOI":"10.1016\/j.jalz.2018.07.211","article-title":"Unintended effects of Z-drugs (zolpidem, zopiclone and zaleplon) in people living with dementia","volume":"14","author":"Richardson","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1471-4159.2007.04832.x","article-title":"GABA A receptors in aging and Alzheimer's disease","volume":"103","author":"Rissman","year":"2007","journal-title":"J. Neurochem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/gps.3769","article-title":"The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease","volume":"27","author":"Rosenberg","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-150630","article-title":"The incidence of benzodiazepine and related drug use in persons with and without Alzheimer's disease","volume":"49","author":"Saarelainen","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/gps.4821","article-title":"Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: a matched cohort study","volume":"33","author":"Saarelainen","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/gps.4821","article-title":"Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: a matched cohort study","volume":"33","author":"Saarelainen","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"","journal-title":"J. Clin. Sleep Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5664\/jcsm.6428","article-title":"Payer perspective of the American academy of sleep medicine clinical practice guideline for the pharmacologic treatment of chronic insomnia","volume":"13","author":"Sateia","year":"","journal-title":"J Clin Sleep Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.pnpbp.2010.01.004","article-title":"Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at \u03b11 plus \u03b15 versus \u03b12 plus \u03b13 subunits account for dissimilarities in behavioral effects in rats?","volume":"34","author":"Savi\u0107","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.sbi.2019.03.023","article-title":"A structural perspective on GABA A receptor pharmacology","volume":"54","author":"Scott","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimers Dement"},{"key":"B82","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABAA receptors","volume":"39","author":"Sigel","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer' s disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol."},{"key":"B84","first-page":"9","article-title":"The effects of benzodiazepines on cognition","volume":"66","author":"Stewart","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.4088\/JCP.08m04593","article-title":"Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-\u03b54 carriers","volume":"70","author":"Stonnington","year":"2009","journal-title":"J. Clin. Psychiatry."},{"key":"B86","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/YIC.0000000000000080","article-title":"Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease","volume":"30","author":"Taipale","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/acps.12909","article-title":"The risk of Alzheimer' s disease associated with benzodiazepines and related drugs: a nested case \u2013 control study","volume":"138","author":"Tapiainen","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"B88","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/YIC.0000000000000161","article-title":"Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease","volume":"32","author":"Tolppanen","year":"2017","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1017\/S1041610217001090","article-title":"Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study","volume":"29","author":"T\u00f6rm\u00e4lehto","year":"2017","journal-title":"Int. Psychogeriatr."},{"key":"B90","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.conb.2018.04.027","article-title":"Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease","volume":"51","author":"Tracy","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JAD-170905","article-title":"Polypharmacy and potentially inappropriate medication in people with dementia: a nationwide study","volume":"63","author":"Underlien","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.5665\/sleep.3052","article-title":"Midlife sleep characteristics associated with late life cognitive function","volume":"36","author":"Virta","year":"2007","journal-title":"Sleep"},{"key":"B93","first-page":"832","article-title":"Pharmacologic treatment of insomnia benzodiazepine receptor agonists,","volume-title":"Principles and Practice of Sleep Medicine, 6th Edn, Vol. 6","author":"Walsh","year":"2016"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/j.1460-9568.2004.03688.x","article-title":"Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory","volume":"20","author":"Wan","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/gps.4900","article-title":"Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: results from the population-based Mayo Clinic Study of Aging","volume":"33","author":"Wennberg","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry."},{"key":"B96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2018.10.027","article-title":"Neurobiology of Aging Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain","volume":"75","author":"Whittington","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"B97","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/JGP.0b013e3181e049ca","article-title":"Effect of benzodiazepine discontinuation on dementia risk","volume":"19","author":"Wu","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.sleep.2018.01.010","article-title":"Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials","volume":"45","author":"Yi","year":"2018","journal-title":"Sleep Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/WAD.0000000000000099","article-title":"Benzodiazepine use and cognitive decline in elderly with normal cognition","volume":"30","author":"Zhang","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B101","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbr.2011.12.013","article-title":"Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice","volume":"228","author":"Zhao","year":"2012","journal-title":"Behav. Brain Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","article-title":"Association between benzodiazepine use and dementia: a meta-analysis","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2019.00344\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T23:57:44Z","timestamp":1578441464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2019.00344\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":102,"alternative-id":["10.3389\/fnagi.2019.00344"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2019.00344","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]},"article-number":"344"}}